Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Prax Kinderpsychol Kinderpsychiatr ; 66(7): 516-525, 2017 Sep.
Artículo en Alemán | MEDLINE | ID: mdl-29557312

RESUMEN

A Multi-arm Placebo-controlled Study with Glutamic Acid Conducted in Rostock in 1953/1954 Glutamic acid was commonly used in the treatment of intellectually disabled children in the 50s. Koch reported first results of an observation of 140 children treated with glutamic acid in 1952. In this line is the multi-arm placebo-controlled study reported here. The original study protocols were available. 58 children with speech problems who attending a school of special needs received glutamic acid, or vitamin B, or St.-John's-wort. The effect of glutamic acid was in few cases an improvement of attention. On the other hand restlessness and stutter increased. The majority of all reported a weight loss. The treatment with vitamin B showed a positive effect concerning concentration. The treatment with St.-John's wort was stopped caused by headache and vomiting in eight of nine cases. The results of the study reported here are unpublished. The reason may be that until the 60s the effects of glutamic acid in the treatment of intellectually disabled children were in generally overestimated.


Asunto(s)
Ensayos Clínicos Controlados como Asunto/historia , Ácido Glutámico/historia , Ácido Glutámico/uso terapéutico , Discapacidad Intelectual/tratamiento farmacológico , Discapacidad Intelectual/historia , Fitoterapia/historia , Extractos Vegetales/historia , Extractos Vegetales/uso terapéutico , Tartamudeo/tratamiento farmacológico , Tartamudeo/historia , Complejo Vitamínico B/historia , Complejo Vitamínico B/uso terapéutico , Niño , Alemania , Historia del Siglo XX , Humanos , Hypericum
3.
Hist. ciênc. saúde-Manguinhos ; 22(4): 1157-1172, out.-dez. 2015. graf
Artículo en Español | LILACS | ID: lil-767022

RESUMEN

Este artículo describe de forma comprehensiva parte del devenir histórico que han tenido, el conocimiento médico de los defectos del tubo neural (DTN) y el descubrimiento de la vitamina B9 o ácido fólico, así como algunos de los acontecimientos investigativos relevantes que a través de varios siglos definieron las relaciones entre la comprensión de la embriología del sistema nervioso central, el descubrimiento de la vitamina, la correlación del ácido fólico con la proliferación celular y finalmente el desarrollo de medidas preventivas de este tipo de defectos. Se pretende, a través de esta narrativa, exponer los conceptos históricamente relevantes que sustentan las acciones de índole clínico y de impacto poblacional que previenen los DTN a través del consumo preconcepcional de ácido fólico.


This article gives a broad overview of part of the historical evolution of medical knowledge about neural tube defects (NTD) and the discovery of vitamin B9 or folic acid, as well as some relevant research events that, over the course of several centuries, defined the relationships between the understanding of central nervous system embryology, the discovery of the vitamin, the correlation between folic acid and cell proliferation and lastly the development of preventive measures for this type of defects. This narrative allows us to examine historically relevant concepts underlying clinical actions with a populational impact that prevent NTDs via folic acid consumption prior to conception.


Asunto(s)
Humanos , Historia del Siglo XIX , Historia del Siglo XX , Ácido Fólico/historia , Defectos del Tubo Neural/historia , Complejo Vitamínico B/historia , Complejo Vitamínico B/uso terapéutico , Ácido Fólico/uso terapéutico , Defectos del Tubo Neural/prevención & control
4.
Hist Cienc Saude Manguinhos ; 22(4): 1157-72, 2015 Dec.
Artículo en Español | MEDLINE | ID: mdl-25650704

RESUMEN

This article gives a broad overview of part of the historical evolution of medical knowledge about neural tube defects (NTD) and the discovery of vitamin B9 or folic acid, as well as some relevant research events that, over the course of several centuries, defined the relationships between the understanding of central nervous system embryology, the discovery of the vitamin, the correlation between folic acid and cell proliferation and lastly the development of preventive measures for this type of defects. This narrative allows us to examine historically relevant concepts underlying clinical actions with a populational impact that prevent NTDs via folic acid consumption prior to conception.


Asunto(s)
Ácido Fólico/historia , Defectos del Tubo Neural/historia , Ácido Fólico/uso terapéutico , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Defectos del Tubo Neural/prevención & control , Complejo Vitamínico B/historia , Complejo Vitamínico B/uso terapéutico
5.
Eur Rev Med Pharmacol Sci ; 18(13): 1896-903, 2014 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-25010620

RESUMEN

Inositol is a physiological compound belonging to the sugar family. The two inositol stereoisomers, myo-inositol and D-chiroinositol are the two main stereisomers present in our body. Myo-inositol is the precursor of inositol triphosphate, a second messenger regulating many hormones such as TSH, FSH and insulin. D-chiroinositol is synthetized by an insulin dependent epimerase that converts myo-inositol into D-chiro-inositol. Polycistic Ovary Syndrome (PCOS) is a metabolic and hormonal disorder and a common cause of infertility. Insulin resistance and the consequent hyperinsulinaemia contribute to hyperandrogenism development, typical marker of PCOS. In these patients myo and/or D-chiro-inositol administration improves insulin sensivity while only myo-inositol is a quality marker for oocytes evaluation. Myo-inositol produces second messengers for FSH and glucose uptake, while D-chiroinositol provides second messengers promoting glucose uptake and glycogen synthesis. The physiological ratio of these two isomers is 40:1 (MI/DCI) and seems to be an optimal approach for the treatment of PCOS disorders.


Asunto(s)
Inositol/historia , Síndrome del Ovario Poliquístico/historia , Complejo Vitamínico B/historia , Animales , Femenino , Historia del Siglo XIX , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Inositol/uso terapéutico , Síndrome del Ovario Poliquístico/tratamiento farmacológico , Complejo Vitamínico B/uso terapéutico
6.
Stud Hist Philos Biol Biomed Sci ; 47 Pt B: 278-89, 2014 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-24268931

RESUMEN

Since the mid-1990s, governments and health organizations around the world have adopted policies designed to increase women's intake of the B-vitamin 'folic acid' before and during the first weeks of pregnancy. Building on initial clinical research in the United Kingdom, folic acid supplementation has been shown to lower the incidence of neural tube defects (NTDs). Recent debate has focused principally on the need for mandatory fortification of grain products with this vitamin. This article takes a longer view, tracing the transformation of folic acid from a routine prenatal supplement to reduce the risk of anaemia to a routine 'pre-conceptional' supplement to 'prevent' birth defects. Understood in the 1950s in relation to social problems of poverty and malnutrition, NTDs were by the end of the century more likely to be attributed to individual failings. This transition was closely associated with a second. Folic acid supplements were initially prescribed to 'high-risk' women who had previously borne a child with a NTD. By the mid-1990s, they were recommended for all women of childbearing age. The acceptance of folic acid as a 'risk-reducing drug' both relied upon and helped to advance the development of preventive and clinical practices concerned with women's health before pregnancy.


Asunto(s)
Suplementos Dietéticos/historia , Ácido Fólico/historia , Defectos del Tubo Neural/historia , Atención Prenatal/historia , Complejo Vitamínico B/historia , Anemia/etiología , Anemia/historia , Anemia/prevención & control , Femenino , Ácido Fólico/uso terapéutico , Historia del Siglo XX , Humanos , Recién Nacido , Defectos del Tubo Neural/etiología , Defectos del Tubo Neural/prevención & control , Política , Embarazo , Conducta de Reducción del Riesgo , Reino Unido , Complejo Vitamínico B/uso terapéutico
7.
Nutrients ; 3(3): 370-84, 2011 03.
Artículo en Inglés | MEDLINE | ID: mdl-22254102

RESUMEN

Periconceptional intake of folic acid is known to reduce a woman's risk of having an infant affected by a neural tube birth defect (NTD). National programs to mandate fortification of food with folic acid have reduced the prevalence of NTDs worldwide. Uncertainty surrounding possible unintended consequences has led to concerns about higher folic acid intake and food fortification programs. This uncertainty emphasizes the need to continually monitor fortification programs for accurate measures of their effect and the ability to address concerns as they arise. This review highlights the history, effect, concerns, and future directions of folic acid food fortification programs.


Asunto(s)
Dieta , Ácido Fólico/uso terapéutico , Alimentos Fortificados , Defectos del Tubo Neural/prevención & control , Resultado del Embarazo , Atención Prenatal , Complejo Vitamínico B/uso terapéutico , Femenino , Ácido Fólico/efectos adversos , Ácido Fólico/historia , Alimentos Fortificados/efectos adversos , Alimentos Fortificados/historia , Historia del Siglo XX , Historia del Siglo XXI , Humanos , Defectos del Tubo Neural/historia , Embarazo , Atención Prenatal/historia , Atención Prenatal/legislación & jurisprudencia , Complejo Vitamínico B/efectos adversos , Complejo Vitamínico B/historia
8.
J Hist Sociol ; 23(4): 517-41, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-21132948

RESUMEN

Canada began to fortify its flour and bread with vitamin B when it entered the Second World War. The decision was informed by the biology of vitamin B and therefore I suggest that the complexity of this political maneuver can best be understood by considering the specificity of the biochemistry of vitamin B. In this paper I will show that the specific biology of vitamin B allowed the Canadian government the possibility of a healthier population under wartime conditions but also allowed the government a variety of means by which to develop and organize food processing practices to this end.


Asunto(s)
Alimentos Fortificados , Programas de Gobierno , Grupos de Población , Salud Pública , Deficiencia de Vitamina B , Pan/economía , Pan/historia , Canadá/etnología , Harina/economía , Harina/historia , Alimentos Fortificados/economía , Alimentos Fortificados/historia , Programas de Gobierno/economía , Programas de Gobierno/educación , Programas de Gobierno/historia , Programas de Gobierno/legislación & jurisprudencia , Historia del Siglo XX , Humanos , Grupos de Población/educación , Grupos de Población/etnología , Grupos de Población/historia , Grupos de Población/legislación & jurisprudencia , Grupos de Población/psicología , Salud Pública/economía , Salud Pública/educación , Salud Pública/historia , Salud Pública/legislación & jurisprudencia , Complejo Vitamínico B/historia , Deficiencia de Vitamina B/etnología , Deficiencia de Vitamina B/historia , Segunda Guerra Mundial
9.
Hist Psychol ; 13(2): 178-95, 2010 May.
Artículo en Inglés | MEDLINE | ID: mdl-20533770

RESUMEN

Working in a psychiatrically innovative environment created by the Government of Saskatchewan, Canada, Abram Hoffer and Humphry F. Osmond enunciated the adrenochrome hypothesis for the biogenesis of schizophrenia in 1952, slightly later proposing and, apparently, demonstrating, in a double-blind study, that the symptoms of the illness could be reversed by administering large doses of niacin. After placing the hypothesis within its ideological framework, the author describes its emergence and elaboration and discusses the empirical evidence brought against it. Hoffer's idiosyncratic diagnostic procedures, especially his creation and use of a supposed biochemical marker for schizophrenia, are examined. The author argues that Hoffer's conceptualization of schizophrenia, as well as his treatment approach, depended on a tautology. Following David Healy, the author treats the adrenochrome hypothesis as a version of a transmethylation theory, thus incorporating it into mainstream psychopharmacology.


Asunto(s)
Adrenocromo/historia , Alucinógenos/historia , Teoría Psicológica , Esquizofrenia/historia , Historia del Siglo XX , Humanos , Dietilamida del Ácido Lisérgico/historia , Modelos Psicológicos , Niacina/historia , Niacina/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/etiología , Complejo Vitamínico B/historia , Complejo Vitamínico B/uso terapéutico
10.
J Biochem ; 147(4): 451-7, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20353954

RESUMEN

Esmond E. Snell (1914-2003) was a giant of B-vitamin and enzyme research. His early research in bacterial nutrition had lead to the discovery of vitamins such as lipoic acid and folic acid, and an anti-vitamin avidin. He developed microbiological assay methods for riboflavin and other vitamins and amino acids, which are still used today. He also investigated the metabolism of vitamins, discovered pyridoxal and pyridoxamine as the active forms of vitamin B(6) and revealed the mechanism of transamination and other reactions catalysed by vitamin B(6) enzymes. His research in later years on pyruvoyl-dependent histidine decarboxylase unveiled the biogenesis mechanism of this first built-in cofactor. Throughout his career, he was a great mentor of many people, all of whom are inspired by his philosophy of science.


Asunto(s)
Coenzimas/historia , Complejo Vitamínico B/historia , Animales , Arthrobacter/enzimología , Arthrobacter/metabolismo , Bioquímica/historia , Coenzimas/aislamiento & purificación , Coenzimas/fisiología , Historia del Siglo XX , Humanos , Lactobacillus/enzimología , Lactobacillus/crecimiento & desarrollo , Lactobacillus/metabolismo , Técnicas Microbiológicas/historia , Ácido Pantoténico/aislamiento & purificación , Ácido Pantoténico/fisiología , Pseudomonas/enzimología , Pseudomonas/metabolismo , Saccharomyces/enzimología , Saccharomyces/crecimiento & desarrollo , Saccharomyces/metabolismo , Vitamina B 6/historia , Vitamina B 6/aislamiento & purificación , Vitamina B 6/fisiología , Complejo Vitamínico B/aislamiento & purificación , Complejo Vitamínico B/fisiología
13.
Ther Umsch ; 51(7): 459-61, 1994 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-8073381

RESUMEN

The history of the discovery of vitamins was initiated by the observation that beriberi is caused by qualitatively poor nutrition rather than by microorganisms. An early theory suggested the formation of toxins by improper cooking, preservation, or storage; however, research soon took another turn. Feeding experiments with standardized food pointed at the existence of 'accessory factors', present in food in small amounts. These factors seemed to be essential for the maintenance of metabolic processes, yet could not be synthesized by the organism. This was the initial spark for a worldwide research boom. The period from 1912 to 1948 saw the isolation and identification of individual factors belonging to a variety of chemical classes collectively labeled as 'vitamins'.


Asunto(s)
Vitaminas/historia , Europa (Continente) , Historia del Siglo XIX , Historia del Siglo XX , Humanos , Complejo Vitamínico B/historia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA